Napatree Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$1.09M Buy
6,560
+604
+10% +$94.5K 0.61% 42
2024
Q4
$861K Buy
5,956
+1,388
+30% +$215K 0.51% 55
2024
Q3
$740K Buy
4,568
+912
+25% +$145K 0.52% 57
2024
Q2
$534K Buy
3,656
+1,249
+52% +$186K 0.43% 75
2024
Q1
$348K Buy
2,407
+84
+4% +$13.4K 0.34% 88
2023
Q4
$364K Buy
+2,323
New +$356K 0.36% 82

Other funds holding JNJ

Napatree Capital's JNJ Position: Q1 2025 in Review

Napatree Capital increased its Johnson & Johnson (JNJ) stake by 10% in Q1 2025, buying an estimated $94.5K and bringing the position to 6,560 shares worth $1.09M. The position accounts for 0.61% of the portfolio, ranked #42.

Napatree Capital first reported a position in JNJ in Q4 2023 and has held it in 6 quarters since. 4,148 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

  • Napatree Capital held 6,560 shares of Johnson & Johnson worth $1.09M as of Q1 2025.
  • Napatree Capital bought 604 Johnson & Johnson shares in Q1 2025, an estimated $94.5K.
  • Johnson & Johnson made up 0.61% of Napatree Capital's portfolio in Q1 2025, its #42 holding.
  • Napatree Capital first reported a position in Johnson & Johnson in Q4 2023 and has held it in 6 quarters since.
  • 4,148 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Napatree Capital's 13F filing for Q1 2025, filed 2 May 2025.